𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries

✍ Scribed by Salvatore Modica; Luca Roncucci; Piero Benatti; Lorenzo Gafà; M. Grazia Tamassia; Luigi Dardanoni; Maurizio Ponz de Leon

Publisher
John Wiley and Sons
Year
1995
Tongue
French
Weight
702 KB
Volume
62
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predominance of normal karyotype in colo
Predominance of normal karyotype in colorectal tumors from hereditary non-polyposis colorectal cancer patients
✍ Martine Muleris; Anne Marie Dutrillaux; Sylviane Olschwang; Remy Jacques Salmon; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

## Abstract We report the cytogenetic study of 9 colorectal tumors arising in patients with hereditary non‐polyposis colorectal cancer (HNPCC). According to the cytogenetic classification of colorectal tumors previously proposed by us, 2 cases were of the trisomic type, 2 were of the monosomic type

Risk of cancer revealed by follow-up of
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: A population-based study
✍ Maurizio Ponz De Leon; Piero Benatti; Monica Pedroni; Romano Sassatelli; Luca Ro 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 618 KB

## Abstract Hereditary non‐polyposis colorectal cancer (HNPCC) is an autosomal dominant disorder characterized by susceptibility to large‐bowel cancer, frequently with early onset and localized in the right colon. Several tumours of other sites may also occur with increased frequency in these famil

Genomic deletions in MSH2 or MLH1 are a
Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: Identification of novel and recurrent deletions by MLPA
✍ C.F. Taylor; R.S. Charlton; J. Burn; E. Sheridan; G.R. Taylor 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

Gene dosage abnormalities account for a significant proportion of the mutations in genes tested in DNA diagnostic laboratories. Detection of these changes has proved a challenge as the methods available to date are time consuming or unreliable. The multiplex ligation-dependent probe assay (MLPA) is